Comorbidity burden may explain adiponectin’s paradox as a marker of increased mortality risk in hemodialysis patients
Abstract Despite experimental evidence of beneficial metabolic, antiatherosclerotic and antiinflammatory effects of the 30 kDa adipokine, adiponectin, maintenance hemodialysis (MHD) patients with high adiponectin blood levels have paradoxically high mortality rates. We aimed to examine the direction...
Sparad:
| Huvudupphov: | , , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
Nature Portfolio
2021-04-01
|
| Serie: | Scientific Reports |
| Länkar: | https://doi.org/10.1038/s41598-021-88558-0 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|